Search Results - "Inogés, S."

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients by Rodríguez-Ruiz, M.E., Perez-Gracia, J.L., Rodríguez, I., Alfaro, C., Oñate, C., Pérez, G., Gil-Bazo, I., Benito, A., Inogés, S., López-Diaz de Cerio, A., Ponz-Sarvise, M., Resano, L., Berraondo, P., Barbés, B., Martin-Algarra, S., Gúrpide, A., Sanmamed, M.F., de Andrea, C., Salazar, A.M., Melero, I.

“…Combination immunotherapy has the potential to achieve additive or synergistic effects. Combined local injections of dsRNA analogues (mimicking viral RNA) and…”
Get full text

Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma by Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S., Fröde, R., Inogés, S., Lòpez-Dìaz de Cerio, A., Soria, E., Villanueva, H., Vancanneyt, G., McCormick, A., Tusé, D., Lenz, J., Butler-Ransohoff, J.-E., Klimyuk, V., Gleba, Y.

“…Animal and clinical studies with plant-produced single-chain variable fragment lymphoma vaccines have demonstrated specific immunogenicity and safety. However,…”
Get full text

P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA‐DIRECTED CAR T‐CELL THERAPY by Ortiz De Landazuri, I., Oliver‐Caldés, A., Español‐Rego, M., Contreras, M. T., Zabaleta, A., Agulló, C., Puig, N., Cabañas, V., González‐Calle, V., Jiménez, R., Inogés, S., Rodríguez‐Otero, P., Martin‐Antonio, B., Reguera, J. L., López‐Diaz de Cerio, A., Benítez‐Ribas, D., Rodríguez‐Lobato, L. G., González, E. A., Rosiñol, L., Yagüe, J., Moraleda, J. M., Urbano‐Ispizua, Á., Mateos, M. V., Juan, M., Paiva, B., Pascal, M., Fernández de Larrea, C.

Get full text

S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA‐DIRECTED CAR‐T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by Fernandez De Larrea, C., González‐Calle, V., Oliver‐Caldés, A., Cabañas, V., Rodríguez‐Otero, P., Español‐Rego, M., Reguera, J. L., López‐Corral, L., Martin‐Antonio, B., Paiva, B., Inogés, S., Rosiñol, L., López‐Díaz de Cerio, A., Tovar, N., López‐Parra, M., Rodríguez‐Lobato, L. G., Sánchez‐Salinas, A., Varea, S., Ortiz‐Maldonado, V., Pérez Simón, J. A., Prósper, F., Juan, M., Moraleda, J. M., Mateos, M. V., Pascal, M., Urbano‐Ispizua, A.

Get full text

Progressive decrease of CD8(high+) CD28+ CD57- cells with ageing by Merino, J, Martinez-Gonzalez, M A, Rubio, M, Inoges, S

Get full text

Anti-idiotype antibodies in cancer treatment by de Cerio, A López-Díaz, Zabalegui, N, Rodríguez-Calvillo, M, Inogés, S, Bendandi, M

“…As a cancer immunotherapy tool, idiotypes (Ids) have been used in different ways over the last three decades, depending on the actual human tumor cell target…”
Get full text

Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients by INOGES, S, MERINO, J, BANDRES, E, DE CASTRO, P, SUBIRA, M. L, SANCHEZ-IBARROLA, A

“…In this study we have examined intracellular cytokines in peripheral blood mononuclear cells (PBMC) of MS patients by flow cytometry (cytokine flow cytometry)…”
Get full text

Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers by Bendandi, M., Tonelli, R., Maffei, R., Botti, S., Turi, C., Sartini, R., Inoges, S., Calvillo, M. Rodriguez, Zinzani, P. L., Pession, A., Pileri, S. A., Paolucci, G.

“…Summary Background: The complementarity determining region 3 (CDR3) of the immunoglobulin (Ig) heavy chain variable region (VH) is the most reliable molecular…”
Get full text

RESULTS OF PHASE II STUDY OF COMBINED IMMUNOTHERAPY WITH RITUXIMAB PLUS LYMPHOKINE‐ACTIVATED KILLER CELLS AS MAINTENANCE IN FOLLICULAR LYMPHOMA PATIENTS by Martinez Calle, N., Diaz De Cerio, A., Pena, E., Garcia Muñoz, R., Panizo, A., Feliu, J., Giraldo, P., Rodriguez, M., Grande, C., Olave, T., Andrade‐Campos, M., Bandres, E., Nuñez, J., Inoges, S., Panizo, C.

Get full text

O6.03 A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE <<DEND/GBM>> TRIAL by Gallego Perez-Larraya, J., Tejada-Solis, S., de Cerio, A. L., Inoges, S., Espinos, J., Diez-Valle, R.

“…BACKGROUND: Immunotherapy is emerging as a promising therapeutic modality for the treatment of glioblastoma (GBM). Recent clinical trials have supported the…”
Get full text

Idiotype vaccines for human B-cell malignancies by Inoges, S, de Cerio, A Lopez-Diaz, Soria, E, Villanueva, H, Pastor, F, Bendandi, M

“…After twenty years of use in humans, customized idiotypic vaccination yet remains a non-approved, experimental therapeutic option for patients with lymphoma…”
Get more information

The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation by Bandrés, E, Merino, J, Vázquez, B, Inogés, S, Moreno, C, Subirá, M L, Sánchez-Ibarrola, A

“…The use of flow cytometry to detect intracellular cytokines at the single cell level has the potential to quantify cytokine production together with the…”
Get full text

The Increase of IFN-γ Production through Aging Correlates with the Expanded CD8+highCD28−CD57+ Subpopulation by Bandrés, E., Merino, J., Vázquez, B., Inogés, S., Moreno, C., Subirá, M.L., Sánchez-Ibarrola, A.

“…The use of flow cytometry to detect intracellular cytokines at the single cell level has the potential to quantify cytokine production together with the…”
Get full text

O6.03A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE «DEND/GBM» TRIAL by Gállego Pérez-Larraya, J., Tejada-Solís, S., de Cerio, A.L., Inogés, S., Espinós, J., Díez-Valle, R.

“…BACKGROUND: Immunotherapy is emerging as a promising therapeutic modality for the treatment of glioblastoma (GBM). Recent clinical trials have supported the…”
Get full text

Abstract P4-13-04: Autologous dendritic cells vaccines combined with neoadjuvant chemotherapy increase total pCR in stages II-III non-overexpressing HER2 breast cancer patients and induce phenotypic changes in peripheral blood by Santisteban, M, López Díaz de Cerio, A, García Cenoz, M, Martín, P, Zubiri, L, Sola, I, Espinós, J, Salgado, E, Fernández Hidalgo, O, Inogés, S

“…Abstract Background Based on the synergistic effect between immuno- and chemotherapy (CT), we have elaborated an autologous vaccine with dendritic cells loaded…”
Get full text

Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support by Pérez-Calvo, J, Martínez-Aguillo, M, García-Rayo, S, Ramón y Cajal, T, Santisteban, M, Ordóñez, J M, Inogés, S, Subirá, M L, Martín-Algarra, S, Brugarolas, A

“…Dose intensity has been related to clinical outcome in several solid tumors. We studied the influence of clinical and cellular parameters on dose intensity…”
Get more information

Platelet contamination and immunomagnetic cellular selection with the Isolex 300i cell‐selection device by Pérez‐Calvo, Javier, Inogés, Susana

Get full text

1029P Addition of dendritic cell vaccines to neoadjuvant chemotherapy in HER2 negative breast cancer patients by Urrizola, A., Solans, B., Bayona, R. Sanchez, Mejías, L., Vilalta, A., Cruz, S. de la, Olartecoechea, B., Rodríguez-Spiteri, N., Hato, L., Díaz de Cerio, A. Lopez, Inoges, S., Eslava, M. Santisteban

Get full text

P5676Safety and immunomodulatory action of epicardial patches combined with allogeneic adipose-derived mesenchymal stem cells in a rodent and porcine model of myocardial infarction by Pelacho, B, Lopez-Diaz De Cerio, A, Inoges, S, Perez-Astenaga, I, Gavira, J J, Abizanda, G, Andreu, E, Crisostomo, V, Bermejo, J, Huss, A, Gil, A G, Koblizek, T, Quintana, L L, Fernandez-Aviles, F, Prosper, F

Get full text

P01.061 Autologous dendritic cells vaccination and standard radio-chemotherapy in patients with newly diagnosed glioblastoma: a retrospective single-center series by Esparragosa, I, Inoges, S, de Cerio, A L, Espinos, J, Aristu, J, Puigdelloses, M, Alonso, M, Tejada-Solis, S, Díez-Valle, R, Gállego Pérez-Larraya, J

“…Abstract Background Immunotherapy is being increasingly investigated as a treatment for glioblastoma (GBM). Recent non-randomized clinical trials and…”
Get full text